High expression levels of insulin-like growth factor-I receptor predict poor survival among women with clear-cell renal cell carcinomas

Human Pathology

Volumn 33, Issue 8, 2002, Pages 801-805

  Parker, Alexander S ^a   Cheville, John C ^a   Janney, Carol A ^a   Cerhan, James R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cohort studies; Insulin like growth factor I receptor; Renal cell carcinoma

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; NONBIOLOGICAL MODEL; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

EID: 0036692208     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.126186     Document Type: Article

References (20)

1. Renal cell carcinoma: Current prognostic factors: Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)
2. Epidemiology of renal carcinoma
3. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases
4. Stage pT1 conventional (clear cell) renal cell carcinoma: Pathologic features associated with cancer specific survival
5. Prognostic features of pathologic stage T 1 renal cell carcinoma after radical nephrectomy
6. Prognostic utility of the recently recommended histologic classification and revised TNM system of renal cell carcinoma: A Swiss experience with 588 tumors
7. Current prognostic factors-Renal cell carcinoma. Workgroup 4
8. The IGF-I receptor in cell growth, transformation, and apoptosis
9. Growth hormone, IGF-I and cancer: Less intervention to avoid cancer? More intervention to prevent cancer?
10. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis
11. Insulin-like growth factors and their binding proteins: Biological actions
12. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines
13. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant
14. Insulin and insulin-like growth factor receptor tyrosine kinase activities in human renal carcinoma
15. Nutrition and other risk factors for renal cell carcinoma in postmenopausal women
16. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer
17. Regression models and life tables (With discussion)
18. Functional form
19. Inhibition of insulin-like growth factor-I-mediated cell signaling by the von Hippel-Lindau gene product in renal cancer
20. Mutations of the VHL tumor suppressor gene in renal carcinoma